Market revenue in 2023 | USD 104.3 million |
Market revenue in 2030 | USD 133.1 million |
Growth rate | 3.5% (CAGR from 2023 to 2030) |
Largest segment | Biologics |
Fastest growing segment | Biologics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications |
Key market players worldwide | ConvaTec Group PLC, 3M Co, Coloplast A/S ADR, Smith & Nephew PLC, Medtronic PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetic foot ulcer treatment market will help companies and investors design strategic landscapes.
Biologics was the largest segment with a revenue share of 36.43% in 2023. Horizon Databook has segmented the Brazil diabetic foot ulcer treatment market based on wound care dressings, biologics, therapy devices, antibiotic medications covering the revenue growth of each sub-segment from 2018 to 2030.
Increase in medical tourism and availability of advanced treatments at affordable cost are the major driving factors for the market. Moreover, well-defined regulatory framework set by health agencies, such as Brazilian Health Regulatory Agency (ANVISA), and availability of experienced professionals are some of the major factors fueling the demand for diabetic foot ulcer treatment products.
In addition, government programs and presence of notable private insurance coverage are expected to drive the market in Brazil over the forecast period. The demand for diabetic care devices and other home health applications for diabetes in Brazil is high. People in Brazil consider using devices manufactured in the U.S., Europe, and Canada.
However, they prefer domestic applications because of their low costs. Manufacturing costs in Brazil are lower than that in developed countries, attracting several market players for investment in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil diabetic foot ulcer treatment market , including forecasts for subscribers. This country databook contains high-level insights into Brazil diabetic foot ulcer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account